Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell and gene therapies in order to enhance their therapeutic effectiveness against a broad range of diseases that conventional medicines do not readily address.
For more information, please visit the Senti Bio website at https://www.sentibio.com.
Company Details
- Employees
- 70
- Founded
- -
- Address
- 2 Corporate Drive,
- co****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sentibio.com
- Keywords
- Synthetic Biology, Gene Therapy, Cell Therapy.
- HQ
- South San Francisco, CA
Senti Biosciences Questions
Senti Biosciences's website is sentibio.com
Senti Biosciences's LinkedIn profile is https://www.linkedin.com/company/senti-biosciences
Senti Biosciences has
70 employees.
View email and phone details for 70
employees at Senti Biosciences.
Senti Biosciences's industry is
Biotechnology Research
Senti Biosciences's top competitors are
Nuvig Therapeutics Inc.,
Coherus Oncology,
Cargo Therapeutics,
Janux Therapeutics,
Allogene Therapeutics,
Nkarta, Inc.,
Muna Therapeutics,
Genefab,
Arsenal Biosciences, Inc.,
Kyverna Therapeutics.
Senti Biosciences's support email address is contact@sentibio.com
Senti Biosciences's categories are Biotechnology Research
Senti Biosciences's founding year is 2016
